The interplay of the Notch signaling in hepatic stellate cells and macrophages determines the fate of liver fibrogenesis
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Hepatic stellate cells (HSCs) known as “master producers” and macrophages as “master regulators”, are the key cell types that strongly contribute to the progression of liver fibrosis. Since Notch signaling regulates multiple cellular processes, we aimed to study the role of Notch signaling in HSCs differentiation and macrophages polarization and to evaluate its implication in liver fibrogenesis. Notch pathway components were found to be significantly upregulated in TGFβ-activated HSCs, inflammatory M1 macrophages and in mouse and human fibrotic livers. Interestingly, inhibition of Notch using a selective γ-secretase inhibitor, Avagacestat, significantly inhibited TGFβ-induced HSC activation and contractility and suppressed M1 macrophages. Additionally, Avagacestat inhibited M1 driven-fibroblasts activation and fibroblasts-driven M1 polarization (nitric oxide release) in fibroblasts and macrophages co-culture and conditioned medium studies. In vivo , post-disease treatment with Avagacestat significantly attenuated fibrogenesis in CCl 4 -induced liver fibrosis mouse model. These effects were attributed to the reduction in HSCs activation and inhibition of inflammatory M1 macrophages and upregulation of suppressive M2 macrophages. These findings suggest that Notch signaling plays a crucial role in HSC activation and M1/M2 polarization of macrophages in liver fibrosis. These results provide new insights for the development of novel therapies against liver fibrosis through modulation of Notch signaling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Bansal et al. (5) showed that components of the Notch signaling pathway -key mediators of cell-cell communication- are upregulated in HSCs, the principal effectors of fibrogenesis, as well as in pro-fibrotic macrophages in both murine and human livers.”
From Strategies to promote liver fibrosis amelioration with involvement of restorative macrophages (2026) · cites this paper as [5]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Avagacestat also promoted deactivation of human LX2 cells, an established HSC cell line.”
From Strategies to promote liver fibrosis amelioration with involvement of restorative macrophages (2026) · cites this paper as [5]
The cited source says what the claim attributes to it.
In the citing paper
“Pharmacological inhibition of Notch signaling using avagacestat, a selective γ-secretase inhibitor, attenuated fibrosis and increased the abundance of pro-resolutive macrophages.”
From Strategies to promote liver fibrosis amelioration with involvement of restorative macrophages (2026) · cites this paper as [5]
In the citing paper
“Notch signaling has been identified as an important driver of HSC activation in fibrosis in general (114, 153).”
From Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH) (2023) · cites this paper as [153]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Macrophage plasticity and polarization: in vivo veritas
Sica, A., & Mantovani, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59643 · Cited by 6,335 · cited 1×
“Additionally, hepatic immunological environment determines the functional plasticity of macrophages varied from classical inflammatory M1 macrophages to alternatively differentiated restorative M2 macrophages 12,29 .”
Protective and pathogenic functions of macrophage subsets
Murray, P. J., & Wynn, T. A. (2011) · Nature Reviews Immunology · doi:10.1038/nri3073 · Cited by 5,269 · cited 3×
“response is predominantly mediated by classically-activated (M1-differentiated) macrophages (activated by Th1 cytokines e.g. IFN-γ , LPS, TNF-α or IL-12) 10–12 .”
The Canonical Notch Signaling Pathway: Unfolding the Activation Mechanism
Kopan, R., & Ilagan, M. X. G. (2009) · Cell · doi:10.1016/j.cell.2009.03.045 · Cited by 3,643 · cited 4×
“Interaction between Notch receptor-and Notch ligand-expressing cells leads to the activation of Notch signaling cascade resulting in the cleavage of ligand-activated Notch receptor by γ -secretase complex 21 .”
InfluentialHepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
Friedman, S. L. (2008) · Physiological Reviews · doi:10.1152/physrev.00013.2007 · Cited by 2,842 · cited 1×
“Owing to liver fibrogenesis, quiescent HSCs become activated to a contractile myofibroblast-like matrix-secreting phenotype and secrete fibrillar colla-gens resulting in deposition of fibrotic matrix and scar-tissue formation 6 .”
Mechanisms of Hepatic Fibrogenesis
Friedman, S. L. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.003 · Cited by 2,634
Schuppan, D., & Afdhal, N. H. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60383-9 · Cited by 2,089
Pathogenesis of Liver Fibrosis
Hernandez-Gea, V., & Friedman, S. L. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130246 · Cited by 1,809
Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair
Duffield, J. S., Forbes, S. J., Constandinou, C. M., Clay, S., Partolina, M., Vuthoori, S., Wu, S., Lang, R., & Iredale, J. P. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522675 · Cited by 1,649 · cited 1×
“Hepatic stellate cells (HSCs) are considered as the major producers of fibrotic ECM during liver fibrosis, but activation of macrophages is also an essential step in the initiation of fibrogenesis and they are signified as positive modulators of fibrosis 25–27 .”
Macrophages: master regulators of inflammation and fibrosis
Wynn, T., & Barron, L. (2010) · Seminars in Liver Disease · doi:10.1055/s-0030-1255354 · Cited by 1,392
Recent Developments in Myofibroblast Biology
Hinz, B., Phan, S. H., Thannickal, V. J., Prunotto, M., Desmoulière, A., Varga, J., De Wever, O., Mareel, M., & Gabbiani, G. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2012.02.004 · Cited by 1,193
Cited by
Macrophage Polarization and Its Role in Liver Disease
Wang, C., Ma, C., Gong, L., Guo, Y., Fu, K., Zhang, Y., Zhou, H., & Li, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.803037 · Cited by 581
Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis
Zhu, C., Kim, K., Wang, X., Bartolome, A., Salomao, M., Dongiovanni, P., Meroni, M., Graham, M. J., Yates, K. P., Diehl, A. M., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aat0344 · Cited by 250
Tanwar, S., Rhodes, F., Srivastava, A., Trembling, P. M., & Rosenberg, W. M. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i2.109 · Cited by 241
Hepatic macrophages: Key players in the development and progression of liver fibrosis
Cheng, D., Chai, J., Wang, H., Fu, L., Peng, S., & Ni, X. (2021) · Liver International · doi:10.1111/liv.14940 · Cited by 188
Li, X., Jin, Q., Yao, Q., Xu, B., Li, L., Zhang, S., & Tu, C. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00072 · Cited by 171
“Recent data have suggested that Notch1 signaling was widely known as a key transcription factor related to M1 macrophage activation (Lawrence and Natoli, 2011; Bansal et al., 2015; Xu et al., 2015a).”
BackgroundHyaluronan synthase 2–mediated hyaluronan production mediates Notch1 activation and liver fibrosis
Yang, Y. M., Noureddin, M., Liu, C., Ohashi, K., Kim, S. Y., Ramnath, D., Powell, E. E., Sweet, M. J., Roh, Y. S., Hsin, I.-F., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aat9284 · Cited by 166
“Notch transcripts are up-regulated in patients with biliary fibrosis (33), and Notch inhibitors suppress TGF-–induced HSC activation and liver fibrosis (18).”
Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH)
Wang, S., & Friedman, S. L. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.adi0759 · Cited by 158
“Notch signaling has been identified as an important driver of HSC activation in fibrosis in general ( 113 , 152 ).”
BackgroundNotch in fibrosis and as a target of anti-fibrotic therapy
Hu, B., & Phan, S. H. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.04.010 · Cited by 157
“Another selective γsecretase inhibitor, Avagacestat, is found to inhibit TGFβ-induced HSC activation and contractility [124].”
BackgroundMacrophage Phenotype in Liver Injury and Repair
Sun, Y. ‐., Li, X. ‐., Meng, X. ‐., Huang, C., Zhang, L., & Li, J. (2017) · Scandinavian Journal of Immunology · doi:10.1111/sji.12468 · Cited by 137
Pathogenesis of NASH: the Impact of Multiple Pathways
Noureddin, M., & Sanyal, A. J. (2018) · Current Hepatology Reports · doi:10.1007/s11901-018-0425-7 · Cited by 134
Desmoplastic Tumor Microenvironment and Immunotherapy in Cholangiocarcinoma
Høgdall, D., Lewińska, M., & Andersen, J. B. (2018) · Trends in cancer · doi:10.1016/j.trecan.2018.01.007 · Cited by 138
Liver fibrosis resolution: from molecular mechanisms to therapeutic opportunities
Pei, Q., Yi, Q., & Tang, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119671 · Cited by 121
Components of the hepatocellular carcinoma microenvironment and their role in tumor progression
Новикова, М. В., Хромова, Н. В., & Kopnin, P. (2017) · Biochemistry (Moscow) · doi:10.1134/s0006297917080016 · Cited by 119
The Carcinogenic Role of the Notch Signaling Pathway in the Development of Hepatocellular Carcinoma
Huang, Q., Li, J., Zheng, J., & Wei, A. (2019) · Journal of Cancer · doi:10.7150/jca.26847 · Cited by 113
Magee, N., Zou, A., & Zhang, Y. (2016) · BioMed Research International · doi:10.1155/2016/5170402 · Cited by 107
“In TGF-β-activated HSCs, Notch pathway components are significantly increased and inhibition of Notch signaling decreases HSC activation [116].”
BackgroundThe innate immune receptor TREM-1 promotes liver injury and fibrosis
Nguyen-Lefebvre, A. T., Ajith, A., Portik-Dobos, V., Horuzsko, D. D., Arbab, A. S., Dzutsev, A., Sadek, R., Trinchieri, G., & Horuzsko, A. (2018) · Journal of Clinical Investigation · doi:10.1172/jci98156 · Cited by 104
Keewan, E., & Naser, S. A. (2020) · Cells · doi:10.3390/cells9010111 · Cited by 98
“It was reported that Notch receptors (Notch1-3) and ligands (DLL-1, DLL-4, and Jagged-1) were upregulated in M1 macrophages compared to M2 and undifferentiated macrophages [86].”
BackgroundAkcora, B. Ö., Storm, G., & Bansal, R. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.12.001 · Cited by 97
Self-citationExtra- and Intra-Cellular Mechanisms of Hepatic Stellate Cell Activation
Yan, Y., Zeng, J., Xing, L., & Li, C. (2021) · Biomedicines · doi:10.3390/biomedicines9081014 · Cited by 96
“In TGF-β-induced human HSCs, fibrosis-related genes (col I and α-SMA), and Notch3, JAG1 and Hes1 were overexpressed compared to non-activated cells [85].”
BackgroundThe Notch signaling pathway regulates macrophage polarization in liver diseases
Chen, W., Liu, Y., Chen, J., Ma, Y., Song, Y., Cen, Y., You, M., & Yang, G. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107938 · Cited by 93
Alhomrani, M., Correia, J., Zavou, M. J., Leaw, B., Kuk, N., Xu, R., Saad, M. I., Hodge, A. D., Greening, D. W., Lim, R., et al. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00748 · Cited by 87
“…cell stimulation using lipopolysaccharide (LPS; 10 ng/ml) and interferon-γ (IFN-γ; 10 ng/ml) (Life Technologies, Frederick, MD, United States), while M2 activation was assessed using interleukins-4 and interleukins-13 (PeproTech, Rocky Hill, NJ, United States) (10 ng/ml each) (Bansal et al., 2015).”
MethodMacrophage Polarization: An Important Candidate Regulator for Lung Diseases
Deng, L., Jian, Z., Xu, T., Li, F., Deng, H., Zhou, Y., Lai, S., Xu, Z., & Zhu, L. (2023) · Molecules · doi:10.3390/molecules28052379 · Cited by 91
Targeting Fibrosis: From Molecular Mechanisms to Advanced Therapies
Di, X., Li, Y., Wei, J., Li, T., & Liao, B. (2024) · Advanced Science · doi:10.1002/advs.202410416 · Cited by 121
Hepatic stellate cells in the injured liver: Perspectives beyond hepatic fibrosis
Ezhilarasan, D. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30582 · Cited by 82
“Delta‐like ligand 4 (DLL4), a ligand of the Notch signaling pathway, is predominantly expressed in LSECs and in the fibrotic liver (Bansal et al., 2015; Shen et al., 2016).”
BackgroundTracing immune cells around biomaterials with spatial anchors during large-scale wound regeneration
Yang, Y., Chu, C., Liu, L., Wang, C., Hu, C., Rung, S., Man, Y., & Qu, Y. (2023) · Nature Communications · doi:10.1038/s41467-023-41608-9 · Cited by 85
Novel Insights on Notch signaling pathways in liver fibrosis
Ni, M.-M., Wang, Y.-R., Wu, W., Xia, C.-C., Zhang, Y.-H., Xu, J., Xu, T., & Li, J. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.02.051 · Cited by 79
Mitogen-Activated Protein Kinases (MAPKs) and Cholangiocarcinoma: The Missing Link
Chen, C., Nelson, L. J., Avila, M. A., & Cubero, F. J. (2019) · Cells · doi:10.3390/cells8101172 · Cited by 71
Notch Signaling in Macrophages in the Context of Cancer Immunity
Palaga, T., Wongchana, W., & Kueanjinda, P. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00652 · Cited by 72
“Similarly, Jagged1, Dll1, and Dll4 are detected in proinflammatory macrophages (18).”
BackgroundA detailed overview of quercetin: implications for cell death and liver fibrosis mechanisms
Xiong, F., Zhang, Y., Li, T., Tang, Y., Song, S., Zhou, Q., & Wang, Y. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1389179 · Cited by 71
Ayazi, M., Zivkovic, S., Hammel, G., Stefanovic, B., & Ren, Y. (2022) · Cells · doi:10.3390/cells11152371 · Cited by 71
Zhang, K., Chang, Y., Shi, Z., Han, X., Han, Y., Yao, Q., Hu, Z., Cui, H., Zheng, L., Han, T., et al. (2016) · Scientific Reports · doi:10.1038/srep30029 · Cited by 61
Regulators of Cholangiocyte Proliferation
Hall, C. M., Sato, K., Wu, N., Zhou, T., Kyritsi, K., Meng, F., Glaser, S. S., & Alpini, G. D. (2016) · Gene Expression · doi:10.3727/105221616x692568 · Cited by 67
Kurniawan, D. W., Jajoriya, A. K., Dhawan, G., Mishra, D., Argemí, J., Bataller, R. A., Storm, G., Mishra, D. P., Prakash, J., & Bansal, R. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.09.004 · Cited by 68
Self-citationAkcora, B. Ö., Storm, G., Prakash, J., & Bansal, R. (2017) · Scientific Reports · doi:10.1038/srep44545 · Cited by 60
“We have also recently shown a Notch-mediated cross-talk between fibroblasts and macrophages in liver fibrosis 11 .”
Self-citationEndothelin-1 in portal hypertension: The intricate role of hepatic stellate cells
Ezhilarasan, D. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370220949148 · Cited by 56
“Delta-like ligand 4 (DLL4), a ligand of the Notch signaling pathway, is predominantly expressed in LSECs and it is one of the factors responsible for the maintenance of liver sinusoidal homeostasis.(50,51) Higher levels of DLL4 were detected in LSECs of CCl4-induced fibrotic liver in mice and in fibrotic human liver.”
BackgroundThe Role of Notch Signaling Pathway in Non-Alcoholic Fatty Liver Disease
Xu, H., & Wang, L. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.792667 · Cited by 43
Tumor microenvironment in primary liver tumors: A challenging role of natural killer cells
Polidoro, M. A., Mikulak, J., Cazzetta, V., Lleò, A., Mavilio, D., Torzilli, G., & Donadon, M. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i33.4900 · Cited by 43
Esmail, M. M., Saeed, N. M., Michel, H. E., & El‐Naga, R. N. (2021) · Toxicology Letters · doi:10.1016/j.toxlet.2021.04.018 · Cited by 37
The versatility of macrophage heterogeneity in liver fibrosis
Gao, C.-C., Bai, J., Han, H., & Qin, H.-Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.968879 · Cited by 37
“Meanwhile, the expression of anti-inflammatory genes expression is upregulated, which contributes to alleviated liver fibrosis (82).”
BackgroundDi, X., Chen, J., Li, Y., Wang, M., Wei, J., Li, T., Liao, B., & Luo, D. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.1545 · Cited by 46
“138,139 In addition to inducing M1 polarisation, the coculture of HSCs and macrophages revealed that HSCs can activate the p38 pathway to induce a distinct subtype of macrophages with both proinflammatory and profibrotic characteristics.”
BackgroundNotch Signaling and Liver Cancer
Kawaguchi, K., & Kaneko, S. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-55031-8_6 · Cited by 39
Regulatory role and translational potential of CCL11 in liver fibrosis
Kong, M., Dong, W., Kang, A., Kuai, Y., Xu, T., Fan, Z., Shi, L., Sun, D., Lu, Y., Li, Z., et al. (2023) · Hepatology · doi:10.1097/hep.0000000000000287 · Cited by 34
“Of interest, Jag1, a ligand for the Notch signaling pathway that has been shown to play a role in liver fibrosis,[29,30] was found to be most F IGURE 2 ZNF281 mediates TGF-induced CCL11 transcription in HSCs.”
BackgroundResultLi, X., Li, Y., Zhang, W., Jiang, F., Lin, L., Wang, Y., Wu, L., Zeng, H., & Zheng, J. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.1793 · Cited by 33
“29,30 Interestingly, Jag1 promotes HSC activation by signalling through Notch1 and Notch3, rather than Notch2 or Notch4, reflecting the results of Kong et al. 28 Yang et al. demonstrated that HSC-specific Notch1 deletion in mice confers resistance to bile duct ligation-induced liver fibrosis.”
BackgroundGenz, B., Coleman, M. A., Irvine, K. M., Kutasovic, J. R., Miranda, M. S., Gratte, F. D., Tirnitz‐Parker, J. E. E., Olynyk, J. K., Calvopina, D. A., Weis, A., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-44865-1 · Cited by 35
Akcora, B. Ö., Gabriël, A. V., Ortiz‐Perez, A., & Bansal, R. (2019) · FASEB BioAdvances · doi:10.1096/fba.2019-00070 · Cited by 29
Self-citationMa, T., Cai, X., Wang, Z., Huang, L., Wang, C., Jiang, S., Hua, Y., & Liu, Q. (2017) · BioMed Research International · doi:10.1155/2017/2670658 · Cited by 28
Hepatic stellate cell-derived exosomes modulate macrophage inflammatory response
Benbow, J. H., Marrero, E., McGee, R. M., Brandon‐Warner, E., Attal, N., Feilen, N. A., Culberson, C. R., McKillop, I. H., & Schrum, L. W. (2021) · Experimental Cell Research · doi:10.1016/j.yexcr.2021.112663 · Cited by 28
Notch1 signaling enhances collagen expression and fibrosis in mouse uterus
Xu, Q., Zhang, W., Liu, X., Yan, W., Lü, L., Song, S., Wei, S., Liu, Y., Kang, J., & Su, R. (2021) · BioFactors · doi:10.1002/biof.1771 · Cited by 25
“In addition, Notch pathway components also upregulate in CCl4-induced liver fibrosis mouse models and human cirrhotic livers.(24) Besides, ALGS patients (in which Jag1 FIGURE 5 (Continued) XU ET AL.”
BackgroundThe Protective Roles of PPARα Activation in Triptolide-Induced Liver Injury
Hu, D., Zhao, Q., Cheng, Y., Xiao, X.-R., Huang, J., Qu, Y., Li, X., Tang, Y., Bao, W.-M., Yang, J., et al. (2019) · Toxicological Sciences · doi:10.1093/toxsci/kfz146 · Cited by 24
Hepatic stellate cells promote angiogenesis via the TGF-β1-Jagged1/VEGFA axis
Jin, X., Yasen, A., Chen, Z., Wang, W., & Li, D. (2018) · Experimental Cell Research · doi:10.1016/j.yexcr.2018.07.045 · Cited by 25
TG101348, a selective JAK2 antagonist, ameliorates hepatic fibrogenesis in vivo
Akcora, B. Ö., Dathathri, E., Ortiz‐Perez, A., Gabriël, A. V., Storm, G., Prakash, J., & Bansal, R. (2019) · The FASEB Journal · doi:10.1096/fj.201900215rr · Cited by 23
Self-citationMesenchymal stem cells-based therapy in liver diseases
Han, H., Jin, W., & Li, X. (2022) · Molecular Biomedicine · doi:10.1186/s43556-022-00088-x · Cited by 25
Arai, J., Otoyama, Y., Nozawa, H., Kato, N., & Yoshida, H. (2022) · Oncogene · doi:10.1038/s41388-022-02583-5 · Cited by 24
“More importantly, Notch signaling can promote the progression of liver fibrosis by inducing the polarization of inflammatory and regenerative macrophages and activating hepatic stellate cells [85].”
BackgroundMašek, J., & Andersson, E. R. (2024) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2023.102302 · Cited by 26
Liver fibrosis in fish research: From an immunological perspective
Cao, Q., Shan, H., Zhao, J., Deng, J., Xu, M., Kang, H., Li, T., Zhao, Y., Liu, H., & Jiang, J. (2023) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2023.108885 · Cited by 19
IL-22 inactivates hepatic stellate cells via downregulation of the TGF-β1/Notch signaling pathway
Chen, E., Cen, Y., Lu, D., Luo, W., & Jiang, H.-X. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.8516 · Cited by 26
“Bansal et al (16) demonstrated the functional effects of Notch signaling on HSC activation and M1/M2 polarization of macrophages in liver fibrosis, although the molecular mechanism remains elusive.”
InfluentialWhat gastroenterologists and hepatologists should know about organoids in 2019
Günther, C., Brevini, T., Sampaziotis, F., & Neurath, M. F. (2019) · Digestive and Liver Disease · doi:10.1016/j.dld.2019.02.020 · Cited by 22
“[81] Bansal R, van Baarlen J, Storm G, Prakash J.”
BackgroundNOTCH and the 2 SASPs of senescence
Hoare, M., & Narita, M. (2017) · Cell Cycle · doi:10.1080/15384101.2016.1248730 · Cited by 19
“Notch1 and downstream signaling are activated after liver injury, where hepatic stellate cells (HSC) become activated, releasing a pro-fibrotic secretome.(6) Pharmacological Notch inhibition reduces liver fibrosis after injury.”
BackgroundPolarization of M2 Tumor-Associated Macrophages (TAMs) in Cancer Immunotherapy
Bui, I., & Bonavida, B. (2024) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.2024053830 · Cited by 20
Maccauro, V., Airola, C., Santopaolo, F., Gasbarrini, A., Ponziani, F., & Pompili, M. (2023) · Life · doi:10.3390/life13040991 · Cited by 18
“On the other hand, M2 polarization is more related to liver fibrosis/cirrhosis progression [25] and development of complications, such as hepatocellular carcinoma (HCC) [26].”
BackgroundImmune Checkpoints and the Immunology of Liver Fibrosis
Tsomidis, I., Voumvouraki, A., & Kouroumalis, E. (2025) · Livers · doi:10.3390/livers5010005 · Cited by 16
Nokkeaw, A., Thamjamrassri, P., Tangkijvanich, P., & Ariyachet, C. (2023) · Cells · doi:10.3390/cells12030378 · Cited by 16
“One study discovers that the phosphorylated Smad2 linker region is associated with increased expression of glycosaminoglycans (GAG) [196], and hyaluronan (HA), a class of GAG, is found to be able to activate HSCs via Notch1 [197], so the phosphorylation of the Smad2 linker region may be associated with HSC activation…”
BackgroundInfluentialChoi, J.-H., Cho, Y. S., Choi, H., Lee, S., Han, H.-J., Lee, J., & Kwon, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043439 · Cited by 15
“Hepatocellular damage caused by liver injury leads to the release of pro-fibrotic factors from infiltrating inflammatory cells, especially macrophages, resulting in the activation of HSCs [10].”
BackgroundConsequences of Amyloid‐β Deficiency for the Liver
Buniatian, G. H., Schwinghammer, U., Tremmel, R., Cynis, H., Weiß, T. S., Weiskirchen, R., Lauschke, V. M., Youhanna, S. C., Ramos, I., Valcárcel, M., et al. (2024) · Advanced Science · doi:10.1002/advs.202307734 · Cited by 10
Rocchi, D., González, J. F., Martín-Cámara, O., Perrone, M. G., Miciaccia, M., Scilimati, A., Decouty‐Pérez, C., Parada, E., Egea, J., & Menéndez, J. C. (2023) · Molecules · doi:10.3390/molecules28145374 · Cited by 8
“Nevertheless, it has been recently described that BV2 microglia, as well as macrophages, turn from rounded to spindle-shaped or multipolar phenotypes in response to various M1 proinflammatory stimuli such as LPS/IFNγ or spinal cord injury conditioned media [43,44].”
BackgroundFujiwara, N., Matsushita, Y., Tempaku, M., Tachi, Y., Kimura, G., Izuoka, K., Hayata, Y., Kawamura, S., Eguchi, A., Nakatsuka, T., et al. (2025) · Hepatology · doi:10.1097/hep.0000000000001360 · Cited by 14
Hepatic Fibrosis and Liver Cancer
Anton, A., Friedman, S. L., & Cogliati, B. (2025) · Seminars in Liver Disease · doi:10.1055/a-2779-4937 · Cited by 11
Research Progress of Chinese Medicine in the Regulation of Liver Fibrosis-Related Signaling Pathways
Zheng, S., Xue, C., Li, S., Qi, W., Zao, X., Li, X., Wang, W., Liu, Q., Cao, X., Zhang, P., et al. (2024) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x24500666 · Cited by 11
The role of the Notch signaling pathway in liver injury and repair
Yue, Z., Ruan, B., Duan, J., Han, H., & Wang, L. (2018) · Journal of Bio-X Research · doi:10.1097/jbr.0000000000000014 · Cited by 7
“[34] In contrast to Notch receptor expression, not all Notch ligands are expressed in the adult liver.”
BackgroundInfluentialJag1 insufficiency alters liver fibrosis via T cell and hepatocyte differentiation defects
Mašek, J., Filipovic, I., Hul, N. V., Belicová, L., Jiroušková, M., Oliveira, D. V., Frontino, A. M., Hankeová, S., He, J., Turetti, F., et al. (2024) · EMBO Molecular Medicine · doi:10.1038/s44321-024-00145-8 · Cited by 6
“To determine whether Jag1 Ndr/Ndr lymphocytes affect fi brotic response to BDL, we analyzed the periportal expression of cytokeratin 19 (CK19, a marker of cholangiocytes), alpha smooth muscle actin (aSMA, myo fi broblast, and HSC marker), and collagen1 (an acute fi brotic marker expressed by HSCs (Iwaisako et al, 2014)).”
InfluentialM1 ‐Like Macrophage May Contribute to the Inflammation and Fibrosis Process of Chronic Hepatitis B
Gao, Y., Yang, P., Guan, Y., Liu, P., Chen, D., & Ning, Q. (2025) · Journal of Viral Hepatitis · doi:10.1111/jvh.70052 · Cited by 6
Kim, J. E., Kim, Y., Bae, J., Yoon, E. L., Kim, H. S., Lee, S. R., Yoon, T. H., & Jun, D. W. (2025) · Archives of Pharmacal Research · doi:10.1007/s12272-025-01534-4 · Cited by 8
“Given its established role in hepatic stellate cell activation and liver fibrosis, the Notch pathway was selected for further investigation (Bansal et al. 2015).”
Sun, Y., He, L., Guo, P., Li, F., Wang, B., Zhang, Y., An, K., & Peng, M. (2023) · Open Medicine · doi:10.1515/med-2023-0634 · Cited by 6
“the fate of HSCs, and suppressing this pathway could effectively block HSC activation [30,31].”
BackgroundThe Role of RECK in Hepatobiliary Neoplasia Reveals Its Therapeutic Potential in NASH
Dashek, R. J., Diaz, C., Chandrasekar, B., & Rector, R. S. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.770740 · Cited by 8
“Importantly, pharmaceutical Notch inhibitors prevent TGF-b-mediated HSC activation in vitro (90) and limit HSC activation and hepatic fibrosis in an animal model of fibrosis (91).”
BackgroundImperfect repair in aging: senescent cells and the hepatic fibrotic niche
Kim, J., Kim, M., & Kim, C. (2026) · BMB Reports · doi:10.5483/bmbrep.2025-0224 · Cited by 6
TGF-β-induced fibrotic scar formation limits recovery of spinal cord injury
Pan, D., Wu, P., Noller, K., Cahan, P., & Cao, X. (2026) · Bone Research · doi:10.1038/s41413-026-00507-7 · Cited by 9
Yao, M., Mao, X., Zhang, Z., Cui, F., Shao, S., & Mao, B. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1289538 · Cited by 9
Developmental Signaling and Organ Fibrosis
Hoeft, K., & Kramann, R. (2017) · Current Pathobiology Reports · doi:10.1007/s40139-017-0136-8 · Cited by 7
Notch1 siRNA and AMD3100 Ameliorate Metabolic Dysfunction-Associated Steatotic Liver Disease
Zhu, C., Cheng, Y., Yang, L., Lyu, Y., Li, J., Zhao, P., Zhu, Y. J., Xin, X., & Yin, L. (2025) · Biomedicines · doi:10.3390/biomedicines13020486 · Cited by 5
“There are also some studies reporting that inhibition of the Notch signaling pathway may be effective in alleviating MASLD through reducing secretion of inflammatory cytokines, inhibiting fibroblast activation and promoting macrophage phenotypic switch to an anti-inflammatory phenotype [46,47].”
Sureshan, M., Saraboji, K., & Jothi, A. (2025) · Molecular Diversity · doi:10.1007/s11030-025-11229-z · Cited by 4
Role of immune cell subsets in liver fibrosis through single-cell RNA sequencing and array
Yang, B., Yuan, J., Zhao, J., & Chen, X. (2025) · Cancer Biomarkers · doi:10.1177/18758592251374861 · Cited by 4
“38 Notably, KC (1) macrophages were identi fi ed to exhibit elevated CD5L expression in this analysis.”
LPS‐Binding Hydrogel for TLR4‐Mediated Microbiota‐Immune Modulation
Chen, J., Wu, C., Yang, R., Chen, Z., Yang, X., Xu, Y., Cheng, X., Sui, H., Zhang, S., Zhu, X., et al. (2025) · Advanced Materials · doi:10.1002/adma.202514484 · Cited by 12
Islam, M. A., Mawya, J., Salma, U., Kasim, N. H. A., & Haque, N. (2025) · World Journal of Stem Cells · doi:10.4252/wjsc.v17.i11.111090 · Cited by 4
Iron‐related intercellular communication in the liver: Main players and mechanisms
Fonseca, Ó., Oliveira, P. J., Muckenthaler, M. U., Moreira, A. C., & Gomes, M. S. (2026) · European Journal of Clinical Investigation · doi:10.1111/eci.70168 · Cited by 3
“131 During MASH, the dysfunction in the hepatocytes' mitochondria leads to an accumulation of lipids.”
Cai, Y., Nie, T., Luo, X., Wu, Y., & Wu, J. (2026) · Acta Biomaterialia · doi:10.1016/j.actbio.2026.01.043 · Cited by 4
Wang, J., Du, M., Meng, L., He, S., Zhu, Y., Yang, Y., Ren, X., Huang, Y., Sun, S., Dong, R., et al. (2023) · Digestive and Liver Disease · doi:10.1016/j.dld.2023.08.039 · Cited by 5
RAGE is a key regulator of ductular reaction-mediated fibrosis during cholestasis
Lam, W.-L. M., Gabernet, G., Poth, T., Sator‐Schmitt, M., Oquendo, M. B., Kast, B., Lohr, S., Ponti, A. D., Weiß, L., Schneider, M., et al. (2025) · EMBO Reports · doi:10.1038/s44319-024-00356-7 · Cited by 4
“In line with previous studies, Notch signaling was upregulated in activated HSCs and Hes1 is transcriptionally active during fi brosis progression (Bansal et al, 2015; Yang et al, 2019).”
Lieke, T., Jung‐Schroers, V., & Rebl, A. (2025) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2025.137260 · Cited by 3
Zhu, X., Wu, S.-Q., Gan, L., Yang, X., Liao, Y.-L., An, N., Fan, R., Huang, J.-L., Tang, G., Zhang, C., et al. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6c00883 · Cited by 2
Hincapie, R., Mantovani, O. M., McFaline‐Figueroa, J. L., & Correa, S. (2026) · Med-X · doi:10.1007/s44258-026-00087-5 · Cited by 4
“This spatially constrained Jag1-Notch2 interaction is consistent with Notch-mediated reinforcement of M1-like over fibrosis-associated M2-like macrophage states [152].”
Bainrauch, A., Šisl, D., Markotić, A., Ostojić, A., Gašparov, S., Lang, V. B., Kovačić, N., Grčević, D., Mrzljak, A., & Kelava, T. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10194621 · Cited by 3
Strategies to promote liver fibrosis amelioration with involvement of restorative macrophages
Aquino, J. B. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1792423 · Cited by 1
Unveiling the cellular and molecular mechanisms of traditional Chinese medicine in hepatic fibrosis
Li, X., Yang, X., Xu, Y., Zhao, Q., Xu, Y., Geng, J., Yin, D., Wang, J., & Song, X. (2026) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2026.121571 · Cited by 2
Notch Signaling in Pediatric Soft Tissue Sarcoma
Cossetti, C., Gualtieri, A., Pomella, S., Carcarino, E., & Rota, R. (2018) · Springer eBooks · doi:10.1007/978-1-4939-8859-4_11 · Cited by 1
Akcora, B. Ö., Storm, G., Prakash, J., & Bansal, R. (2017) · Journal of Hepatology · doi:10.1016/s0168-8278(17)31773-7
Self-citationIshifune, C., & Yasutomo, K. (2017) · Springer eBooks · doi:10.1007/978-981-10-4971-2_3
Mizuno, S., & Osaki, E. (2020) · Springer eBooks · doi:10.1007/978-3-030-24432-3_6
The role of the Notch signaling pathway in liver fibrogenesis.
Lebedeva, E. I. (2020) · Morphologia · doi:10.26641/1997-9665.2020.1.7-15
Chen, C. S., & Drain, A. P. (2021) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.735983425.793583678
Metadata
- Authors
- Bansal, R., van Baarlen, J., Storm, G., & Prakash, J.
- Affiliations
- University of Twente (NL)
- Utrecht University (NL)
- Corresponding author
- Bansal, Ruchi
- Prakash, Jai
- Venue
- Scientific Reports
- Published
- 2015-12-14
- Volume
- 5
- Issue
- 1
- Pages
- 18272-18272
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC4677309
- OpenAlex
- W2375249898
- Cited by
- 107
- References
- 42
- Citations by year
- 2026: 10 · 2025: 14 · 2024: 10 · 2023: 12 · 2022: 7 · 2021: 12 · 2020: 7 · 2019: 8 · 2018: 13 · 2017: 8 · 2016: 6
- FWCI
- 5.33
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- University of Twente Research Information (publishedVersion, cc-by)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- University of Twente Research Information (submittedVersion, cc-by)
- Funders
- University of Twente
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Keywords
- Notch signaling, hepatic stellate cells, liver fibrosis, macrophage polarization, M1/M2 macrophages, gamma-secretase inhibitors, TGF-beta, hepatic stellate cell activation, CCl4-induced fibrosis, fibroblast activation, nitric oxide
- MeSH terms
- Animals, Cell Communication, Cell Differentiation, Cell Line, Disease Models, Animal, Fibroblasts, Humans, Liver Cirrhosis, Macrophage Activation, Macrophages, Oxadiazoles, Sulfonamides, Signal Transduction, Transforming Growth Factor beta, 3T3 Cells, Mice, Receptors, Notch, Hepatic Stellate Cells, Chemical and Drug Induced Liver Injury
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.